Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abametapir Lotion Irritation Potential Study
NCT02061813Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jan 2014
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of abametapir in pediculosis capitis (4 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Potential of Abametapir Lotion to Cause Irritation After Repeated Topical Application to the Healthy Skin of Humans at 21 days. Started Jan 2014; status: completed.
02
Drugs
abametapir
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on NCT02061813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061813.